Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

Evaluation of protein C and protein S levels during oral anticoagulant therapy.

O'Brien AE, Tate GM, Shiach C.

Clin Lab Haematol. 1998 Aug;20(4):245-52.

PMID:
9777272
2.
3.

Detection of protein C deficiency during oral anticoagulant therapy--use of the protein C:factor VII ratio.

Jones DW, Mackie IJ, Winter M, Gallimore M, Machin SJ.

Blood Coagul Fibrinolysis. 1991 Jun;2(3):407-11.

PMID:
1932526
4.

Changes in levels of factor VII and protein S after acute myocardial infarction: effects of low-dose warfarin.

Holm J, Hillarp A, Erhardt L, Berntorp E.

Thromb Res. 1999 Nov 1;96(3):205-12.

PMID:
10588463
5.

Plasma levels of factors II, VII and X and their relationship to the international normalized ratio during chronic warfarin therapy.

Lind SE, Callas PW, Golden EA, Joyner KA Jr, Ortel TL.

Blood Coagul Fibrinolysis. 1997 Jan;8(1):48-53.

PMID:
9105637
6.

Unbalanced protein S deficiency due to warfarin treatment as a possible cause for thrombosis.

Haran MZ, Lichman I, Berebbi A, Weinmann E, Rosenberg N.

Br J Haematol. 2007 Oct;139(2):310-1.

PMID:
17897308
7.

Correlation between different intensities of anti-vitamin K treatment and coagulation parameters.

Jerkeman A, Astermark J, Hedner U, Lethagen S, Olsson CG, Berntorp E.

Thromb Res. 2000 Jun 15;98(6):467-71.

PMID:
10899345
8.

Influence of warfarin therapy on activated factor VII clotting activity.

Lippi G, Montagnana M, Salvagno GL, Poli G, Franchini M, Guidi GC.

Blood Coagul Fibrinolysis. 2006 Apr;17(3):221-4.

PMID:
16575262
9.

Detection of protein C or protein S deficiency in patients on warfarin therapy--a study of nine patients.

Linn YC, Tien SL.

Ann Acad Med Singapore. 1994 Sep;23(5):775-80. Review.

PMID:
7847765
10.
11.

Oral anticoagulant therapy and international normalized ratios in swine.

McGlasson DL, Brickey DA, Doe RH.

Lab Anim Sci. 1998 Aug;48(4):371-3.

PMID:
10090045
12.

Plasma levels of protein C and vitamin K-dependent coagulation factors in patients on long-term oral anticoagulant therapy.

Takahashi H, Hanano M, Hayashi S, Arai Y, Yoshino N, Takakuwa E, Tatewaki W, Nagayama R, Takizawa S, Shibata A.

Tohoku J Exp Med. 1986 Aug;149(4):351-7.

13.

Decline of proteins C and S and factors II, VII, IX and X during the initiation of warfarin therapy.

Weiss P, Soff GA, Halkin H, Seligsohn U.

Thromb Res. 1987 Mar 15;45(6):783-90.

PMID:
2954263
14.
15.

Plasma levels of endothelial protein C receptor respond to anticoagulant treatment.

Stearns-Kurosawa DJ, Swindle K, D'Angelo A, Della Valle P, Fattorini A, Caron N, Grimaux M, Woodhams B, Kurosawa S.

Blood. 2002 Jan 15;99(2):526-30.

16.

Evaluation of a new screening assay ProC Global for identification of defects in the protein C/protein S anticoagulant pathway.

Ruzicka K, Kapiotis S, Quehenberger P, Handler S, Pabinger-Fasching I, Mannhalter C, Jilma B, Speiser W.

Thromb Res. 1997 Sep 15;87(6):501-10.

PMID:
9330432
17.

Warfarin or acenocoumarol: which is better in the management of oral anticoagulants?

Barcellona D, Vannini ML, Fenu L, Balestrieri C, Marongiu F.

Thromb Haemost. 1998 Dec;80(6):899-902.

PMID:
9869157
18.

The effect of the plasma levels of proteins C and S on the prediction of warfarin maintenance dose requirements.

Lubetsky A, Seligsohn U, Ezra D, Halkin H.

Clin Pharmacol Ther. 1992 Jul;52(1):42-9.

PMID:
1385564
19.

A comparison of the efficacy and rate of response to oral and intravenous Vitamin K in reversal of over-anticoagulation with warfarin.

Watson HG, Baglin T, Laidlaw SL, Makris M, Preston FE.

Br J Haematol. 2001 Oct;115(1):145-9.

PMID:
11722425
20.

Warfarin-induced benign acral cutaneous lesions in two cardiac patients with decreased protein C and S activity.

Vural M, Usta S, Kaya R.

Anadolu Kardiyol Derg. 2008 Aug 7;8(4):E22. No abstract available.

Supplemental Content

Support Center